期刊文献+

凋亡相关基因FAS及其配体FASL基因单核苷酸多态与大肠癌风险 被引量:3

Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer
原文传递
导出
摘要 目的凋亡相关基因FAS及其配体FASL系统与肿瘤发生关系密切。本研究主要探讨FAS1377G/A和FASL844T/C多态与大肠癌风险的关系。方法采用聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)分析方法,检测了382例大肠癌患者和648例配对的正常对照者FAS1377G/A和FASL844T/C多态基因型,比较不同基因型与大肠癌发生的关系。结果与FAS1377GG基因型和FASL844TT基因型者相比,FAS1377AA基因型和FASL844CC基因型携带者罹患大肠癌的风险分别增加了64.0%(95%CI,1.11~2.44)和69.0%(95%CI,1.03~2.78)。同时,我们发现这两个多态在大肠癌发生过程中存在明显的基因基因交互作用,同时携带FAS1377AA和FASL844CC基因型者发生大肠癌的风险是同时携带FAS1377GG/GA和FASL844TT/TC基因型者的3.6倍(95%CI,2.09~3.60)。结论凋亡相关基因FAS1377G/A及其配体FASL844T/C多态可能是中国人大肠癌的遗传易感因素。 Objective The FAS and FASL system plays a key role in regulating apoptotic cell death and corruption of this signaling pathway has been shown to participate in tumorigenesis. We previously have shown that the FAS-1377G/A and FASL-844T/C polymorphisms are associated with esophageal cancer. This case-control study was to examine the contribution of the polymorphisms to susceptibility of colorectal cancer.Methods PCR-RFLP method was used to determine the genotypes of FAS-1377G/A and FASL-844T/C in 382 patients with colorectal cancer and 648 controls. The adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using logistic regression model. Results The subjects with the AA genotype of FAS-1377G/A and CC genotype of FASL-844T/C had an increased risk for colorectal cancer compared with those with the FAS-1377GG genotype ( adjusted OR, 1.65 ; 95% CI, 1.14-2. 38 ) and FASL-844TT genotype (adjusted OR, 1.76; 95% CI, 1.37-2.28 ). Furthermore, the effect of FAS and FASL polymorphisms on risk of colorectal cancer displayed a significantly gene-gene interaction (liklihood ratio test, P = 0. 002). Conclusion These findings suggest that the FAS-1377G/A and FASL-844T/C polymorphisms may be genetic susceptibility factors for colorectal cancer among Chinese population.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第30期2132-2135,共4页 National Medical Journal of China
基金 国家杰出青年科学基金资助项目(39825122) 北京市科委重大项目(H02090030290)
关键词 结肠肿瘤 直肠肿瘤 FAS/FASL 基因多态 分子遗传学 Colorectal neoplasm FAS/FASL Polymorphism Molecular genetics
  • 相关文献

参考文献13

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Evan GI, Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature,2001, 17: 342-348.
  • 3Suda T, Takahashi TI Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell,1993,75:1169-1178.
  • 4Nagata S, Golstein P. The Fas death factor. Science, 1995, 267:1449-1456.
  • 5Muschen M, Warskulat U, Beckmann MW. Defining CD95 as a tumor suppressor gene. J Mol Med,2000 ;78:312-325.
  • 6Sibley K, Rollinson S, Allan JM, Smith AG. , Law GR, Roddam PL, et 81. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. -Cancer Res,2 003,3 : 327-4330.
  • 7Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC, et al. A novel polymorphie CAAT/enhaneer-binding protein ? element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol,2 003,170:132-138.
  • 8张明刚,李靖涛,杨华元,赵洪川.1134例大肠癌临床病例分析[J].中华医学杂志,2003,83(23):2087-2088. 被引量:33
  • 9Butler LM, Hewer PJ, Butler WJ, Cowled PA. Down-regulation of Fas gene expression in colon cancer is not a result of allelic loss or gene rearrangement. Br J Cancer,1998,77:1454-1459.
  • 10Belluco C, Esposito G, Bertorelle R, Alaggio R, Giacomelli L,Bianchi LC, Nitti D, Lise M. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence. Eur J Surg Oncol, 2002,28 : 120-125.

二级参考文献9

  • 1张亚历,聂军,周杰,郭文,关彩平,周殿元.中国青年大肠癌的发病特点及地理分布[J].中华消化内镜杂志,1997,14(1):11-14. 被引量:74
  • 2Imperiale TF, Wagner DR, Lin CY,et al. Results of screening colonoscopy among persons 40 to 49 years of age.N Engl J Med, 2002,346:1781-1785.
  • 3Platz EA, Giovannucci E, Rimm EB, et al.Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev, 1997,6:661-670.
  • 4Nelson RL, Dollear T, Freels S, et al. The relation of age , race, and gender to the subsite location of colorectal cancer and age. Cancer, 1997,80:193-197.
  • 5Cooper GS,Yuan Z,Landefeld S,et al.A national population-based study of incidence of colorectal cacer and age.Cancer,1995,75:775-778.
  • 6Ikeda Y,Oda S,Abe T,et al.Features of microsatellite instability in colorectal cancer:comparison between colon and rectum.Oncology, 2001,61:168-174.
  • 7Togo G, Yoshida H.Kawabe T,et al.Relationship between age and site of colorectal cancer based on colonoscopy findings. Gastrointest Endosc, 2002,4.55:548-551.
  • 8Chiang JM,Chen MC,Changchien CR,et al. Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum, 2003,46:904-910.
  • 9余细球,卢葵花,徐魁,周燕红,程芳州.青年人大肠癌32例临床对照分析[J].中国综合临床,2002,18(12):1107-1108. 被引量:12

共引文献900

同被引文献25

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2The International HapMap Consortium. The International HapMap Project. Nature, 2003,426:789--796.
  • 3Whiteside T L, Rabinovcich H. The role of Fas/FasL in immunosuppression induced by human tumors. Cancer Immunol Immunother, 1998,46:175 -184.
  • 4Leithauser F, Dhein J, Mechtersheimer G,et al. Constitutive and induced expression of APO 1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest, 1993,69 : 415-- 429.
  • 5Evan G I, Vousden K H. Proliferation, cell cycle and apoptosis in cancer. Nature, 2001,411:342--348.
  • 6Nagata S, Golstein P. The Fas death factor. Science, 1995, 267: 1449-- 1456.
  • 7Reichmann E. The biological role of the Fas/FasL system during tumor formation and progression. Semin Cancer Biol, 2002,12 : 309-- 315.
  • 8Kase H, Aoki Y, Tanaka K. Fas ligand expression in cervical adenocarcinoma: relevance to lymph node metastasis and tumor progression. Gynecol Oncol, 2003,90 :70-- 74.
  • 9Ropponen K M, Eskelinen M J, Lipponen P K, et al. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol,1997,182:318--324.
  • 10MuschenM, Warskulat U, BeekmannMW. Defining CD95 as a tumor suppressor gene. J Mol Med, 2000, 78: 312--325.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部